@article{797fc9ec323d4ee4b834765636aebdfb,
title = "Transforming cancer drug discovery with Big Data and AI",
keywords = "artificial intelligence, Big Data, Big Knowledge, cancer, data analytics, data integration, drug discovery, machine learning, multidisciplinary data",
author = "Paul Workman and Antolin, {Albert A.} and Bissan Al-Lazikani",
note = "Funding Information: P Workman (PW) and B Al-Lazikani (BAL) are funded by a CRUK programme grant to the CRUK Cancer Therapeutics Unit (C309/A11566) and by a CRUK Strategic Award (C35696/A23187). PW is a CRUK Life Fellow. A Antolin (AA) is supported by a Wellcome Trust Sir Henry Wellcome Postdoctoral Fellowship (204735/Z/16/Z). The authors acknowledge support from the CRUK Centre and Biomedical Research Centre at the Institute of Cancer Research (ICR) and Royal Marsden. The authors thank many collaborators for discussions and valuable input into the preparation of this manuscript.",
year = "2019",
month = nov,
day = "2",
doi = "10.1080/17460441.2019.1637414",
language = "English (US)",
volume = "14",
pages = "1089--1095",
journal = "Expert Opinion on Drug Discovery",
issn = "1746-0441",
publisher = "Informa Healthcare",
number = "11",
}